Boosting Pharmaceutical Innovation in the Post-TRIPS Era

Kilic, Burcu

doi:10.4337/9781782544135

Search citation statements

Order By: Relevance

Paper Sections

Select...

A Network Analysis Of Covid-19 Mrna Vaccine Patents1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

2021

Publication Types

Select...

Article2

Book1

Relationship

Self Cite1

Independent2

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, the underlying technology used to develop a vaccine can be protected by patents, while manufacturing methods and techniques (know-how) can be protected by trade secrets. Therapeutic development programs tend to consist of an intricate relationship between an inventor and an innovator 2 . The foundational technology needed to develop a vaccine could have been invented in an academic lab setting or startup research firm, protected through patents, and subsequently licensed out to a larger entity for further development and commercialization.…”

Section: A Network Analysis Of Covid-19 Mrna Vaccine Patentsmentioning

confidence: 99%